HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jérôme Fayette Selected Research
Jérôme Fayette Research Topics
Disease
25
Squamous Cell Carcinoma of Head and Neck
12/2021 - 06/2010
14
Neoplasms (Cancer)
01/2022 - 11/2003
11
Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 08/2011
10
Sarcoma (Soft Tissue Sarcoma)
01/2010 - 07/2005
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 08/2011
3
Lung Neoplasms (Lung Cancer)
12/2020 - 11/2003
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2020 - 10/2015
3
Fatigue
10/2019 - 05/2015
3
Exanthema (Rash)
10/2019 - 05/2013
3
Neutropenia
05/2015 - 02/2008
2
Acne Vulgaris
10/2019 - 05/2015
2
Stomatitis
10/2019 - 05/2015
2
Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2018 - 01/2017
2
Disease Progression
12/2017 - 01/2017
2
Anemia
05/2006 - 12/2003
2
Osteosarcoma (Osteogenic Sarcoma)
03/2006 - 07/2005
1
Genomic Instability
12/2021
1
Tertiary Lymphoid Structures
01/2021
1
Brain Neoplasms (Brain Tumor)
12/2020
1
Diarrhea
10/2019
1
Nausea
10/2019
1
Pain (Aches)
01/2017
1
Infections
01/2016
1
Body Weight (Weight, Body)
10/2015
1
Dermatitis
01/2015
1
Weight Loss (Weight Reduction)
01/2015
1
Renal Insufficiency (Renal Failure)
01/2015
1
Mucositis
01/2015
1
Hypopharyngeal Neoplasms
09/2014
1
Cardiovascular Diseases (Cardiovascular Disease)
05/2013
1
Thrombocytopenia (Thrombopenia)
02/2008
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2008
1
Leiomyosarcoma
08/2006
1
Febrile Neutropenia
05/2006
1
Rhabdomyosarcoma
03/2006
1
Carcinogenesis
11/2003
Drug/Important Bio-Agent (IBA)
9
Platinum
IBA
01/2021 - 10/2012
8
Cetuximab (Erbitux)
FDA Link
01/2021 - 10/2012
8
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 06/2010
8
Docetaxel (Taxotere)
FDA Link
01/2021 - 08/2006
6
Fluorouracil (Carac)
FDA Link
Generic
01/2021 - 10/2012
5
Nivolumab
IBA
12/2020 - 10/2015
4
Methotrexate (Mexate)
FDA Link
Generic
10/2019 - 07/2005
4
Trabectedin
IBA
01/2010 - 11/2005
4
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2010 - 11/2005
3
Phosphotransferases (Kinase)
IBA
12/2021 - 03/2007
3
Paclitaxel (Taxol)
FDA Link
Generic
01/2021 - 06/2010
3
Ligands
IBA
01/2019 - 10/2015
3
Pharmaceutical Preparations
IBA
01/2016 - 07/2006
3
Ifosfamide
FDA Link
Generic
10/2009 - 11/2005
3
Imatinib Mesylate (Gleevec)
FDA Link
01/2008 - 07/2005
2
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2016
2
Immune Checkpoint Inhibitors
IBA
01/2021 - 05/2020
2
ErbB Receptors (EGF Receptor)
IBA
12/2020 - 11/2003
2
Afatinib
IBA
10/2019 - 05/2015
2
durvalumab
IBA
01/2019 - 01/2019
2
Tyrosine Kinase Inhibitors
IBA
05/2015 - 03/2007
2
Taxoids (Taxanes)
IBA
08/2011 - 06/2010
2
Cytotoxins (Cytolysins)
IBA
08/2006 - 07/2005
1
trametinib
IBA
01/2022
1
Mitogen-Activated Protein Kinases
IBA
01/2022
1
Macrophage Colony-Stimulating Factor
IBA
01/2022
1
B7-H1 Antigen
IBA
01/2021
1
pembrolizumab
IBA
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2020
1
tremelimumab
IBA
01/2019
1
Monoclonal Antibodies
IBA
01/2019
1
monalizumab
IBA
12/2018
1
NK Cell Lectin-Like Receptor Subfamily C
IBA
12/2018
1
Complement System Proteins (Complement)
IBA
12/2018
1
Neuregulin-1 (Neuregulin 1)
IBA
01/2016
1
MEHD7945A
IBA
01/2016
1
Analgesics (Analgesic Drugs)
IBA
01/2015
1
Carcinogens
IBA
07/2013
1
Lapatinib (GW572016)
FDA Link
05/2013
1
Capecitabine (Xeloda)
FDA Link
11/2012
1
Transaminases (Aminotransferases)
IBA
01/2010
1
Dacarbazine (DIC)
FDA Link
Generic
10/2009
1
Enzymes
IBA
02/2008
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
03/2007
1
Sunitinib (Sutent)
FDA Link
03/2007
1
Gemcitabine
FDA Link
08/2006
1
Cytokines
IBA
05/2006
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
05/2006
1
Reduced Folate Carrier Protein
IBA
07/2005
1
Erythropoietin
FDA Link
12/2003
1
Epidermal Growth Factor (EGF)
IBA
11/2003
Therapy/Procedure
22
Drug Therapy (Chemotherapy)
01/2021 - 07/2005
10
Radiotherapy
12/2021 - 07/2005
9
Therapeutics
01/2022 - 11/2003
4
Immunotherapy
01/2022 - 01/2018
4
Induction Chemotherapy
01/2019 - 08/2011
3
Adjuvant Chemotherapy
01/2021 - 03/2006
2
Laryngectomy
09/2014 - 05/2014
2
Neoadjuvant Therapy
11/2006 - 03/2006
1
Adjuvant Radiotherapy
01/2022
1
Precision Medicine
01/2021
1
Chemoradiotherapy
05/2013
1
Surgical Amputation (Amputations)
11/2006